Evidence map›Paper›PMID 24943867›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2014

Brief Report: identification of MTMR3 as a novel susceptibility gene for lupus nephritis in northern Han Chinese by shared-gene analysis with IgA nephropathy.

Xu-Jie Zhou, Swapan K Nath, Yuan-Yuan Qi, Fa-Juan Cheng, Hai-Zhen Yang, Yan Zhang, Wanling Yang, Jian-Yang Ma, Ming-Hui Zhao, Nan Shen and 1 more

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Autophagy pathways in autoimmune diseases.Journal of autoimmunity · 2023
    Review
  4. Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis.Translational research : the journal of laboratory and clinical medicine · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. IL-1Journal of immunology research · 2017
    Article
  17. Article
  18. Review
  19. Autophagy in Chronic Kidney Diseases.Kidney diseases (Basel, Switzerland) · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Xu-Jie ZhouPeking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, and Key Laboratory of Chronic Kidney Disease Prevention and Treatment at Peking University, Ministry of Education of China, Beijing, China.
Swapan K Nath
Yuan-Yuan Qi
Fa-Juan Cheng
Hai-Zhen Yang
Yan Zhang
Wanling Yang
Jian-Yang Ma
Ming-Hui Zhao
Nan Shen
Hong Zhang
Peking University · CNChinese Academy of Sciences · CNPeking University First Hospital · CNUniversity of Hong Kong · HKUniversity of Oklahoma Health Sciences Center · US

Funding

SLE Susceptibility and Clinical Significance at 2q22-24 across Multiple EthnicitiR01AR060366 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI NATH, SWAPAN K. · 2010 to 2019
$3.3M
NADPH-Oxidase and SLE SusceptibilityR21AI103399 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI NATH, SWAPAN K. · 2013 to 2014
$462k
NIAID NIH HHS AI-103399NIAID NIH HHS R21 AI103399NIAMS NIH HHS AR-060366NIAMS NIH HHS R01 AR060366
6 · The paper itself

Abstract

objectiveSeveral novel susceptibility genes for systemic lupus erythematosus (SLE) and IgA nephropathy have been identified in recent genome-wide association studies. Since both lupus nephritis and IgA nephropathy are autoimmune diseases of the kidney, they may share common disease mechanisms that overlap with genetic susceptibility. To test this hypothesis, we sought to identify genetic variants associated with IgA nephropathy in lupus nephritis.

methodsIn the first stage, 500 patients with lupus nephritis, 240 SLE patients without nephritis, and 500 healthy controls were enrolled. Fifteen single-nucleotide polymorphisms (SNPs) that had the topmost association signals with IgA nephropathy were selected for further testing in patients with lupus nephritis. Three independent cohorts from Beijing, Shanghai, and Hong Kong were included as replicates. We also analyzed the functional significance of identified noncoding variants on regulatory motifs and gene expression. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated.

resultsIn addition to associations with HLA gene polymorphisms, genetic variants of MTMR3 in 22q12 showed associations with lupus nephritis (for rs9983A, OR 1.61 [95% CI 1.19-2.19], P = 2.07 × 10(-3) ) compared to healthy controls in the first stage. Associations were replicated and reinforced among northern Han Chinese (for lupus nephritis patients versus SLE patients without nephritis, P = 0.01) but not southern Han Chinese, although significant genetic heterogeneity was observed. Conservative and regulatory features of rs9983 were predicted in in silico analyses. In expression analysis, we observed lower MTMR3 transcription levels in samples of blood with rs9983A and in renal biopsy samples from lupus nephritis and IgA nephropathy patients.

conclusionOur results suggest that the MTMR3 gene is shared between IgA nephropathy and lupus nephritis in the northern Chinese population, further highlighting the role of autophagy in SLE. However, widespread replication of these experiments, fine mapping, and functional assays are required to establish this connection.

Indexed as

Polymorphism, Single NucleotideAdultAsian PeopleChinaFemaleGene FrequencyGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeGlomerulonephritis, IGAHong KongHumansLupus NephritisMaleProtein Tyrosine Phosphatases, Non-ReceptorMTMR3 protein, humanProtein Tyrosine Phosphatases, Non-Receptor

Identifiers

PMID24943867
PMCPMC4180767
OpenAlexW2151385256

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.